epitope-selective antibodies exhibit precise target selectivity that confers enhanced safety and pharmacodynamic properties. RubrYc’s discovery engine takes advantage of recent improvements in ...

Monoclonal antibodies (mAbs) are nature's biological ... because of unexpected side effects or poor pharmacokinetics and pharmacodynamics not anticipated from preclinical studies.

CHATHAM, N.J. - Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), a clinical-stage biotech company with a market capitalization of $28 million, announced today positive outcomes from its Phase 1 ...

Objectives: To describe allergic asthma and allergic rhinitis pathophysiology and review the pharmacologic, pharmacokinetic, pharmacodynamic ... is a monoclonal antibody targeting the high ...

Shares of Vigil Neuroscience , Inc. (NASDAQ:VIGL) climbed 14% after the company reported favorable results from its Phase 1 clinical trial for VG-3927, a potential treatment for Alzheimer's disease ...

The best associations among omalizumab dose, suppression of free IgE concentration, and outcome are described in clinical trials involving patients with SAR. In the initial dose-ranging study ...

Initial pharmacokinetic and pharmacodynamic data from the ongoing ... Our candidates feature an antibody connected to a modified immunomodulatory protein, such as a cytokine.